News & Analysis as of

Counterfeit Drugs Counterfeiting Intellectual Property Protection

McDonnell Boehnen Hulbert & Berghoff LLP

U.S. Trade Representative Releases 2023 Special 301 Report

In April, Ambassador Katherine Tai, U.S. Trade Representative (USTR), issued the 2024 Special 301 Report.  In a press release, the USTR stated that "[m]any of the issues highlighted in the Special 301 Report demand...more

Dechert LLP

UK Life Sciences and Healthcare Newsletter: Counterfeit Medicines: A Growing Threat to Consumers and Pharmaceutical Companies

Dechert LLP on

The European Union Intellectual Property Office (“EUIPO”) and Organisation for Economic Co-Operation and Development (“OECD”) recently published a Report on counterfeit pharmaceuticals based on global customs seizure data...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide